Although cancer genomics is a powerful tool to understand cancer and develop diagnostic tools, the contribution of the microbiome in cancer diagnosis and clinical assessment is much less studied. Elinav, Greten and colleagues provide their respective views on how studying cancer metagenomes could facilitate identification, diagnosis and staging of different tumor types.
Editorial material
Microbiome genomics for cancer prediction
Nature Cancer, Vol.1(4), pp.379-381
Apr/2020
Abstract
Details
- Title
- Microbiome genomics for cancer prediction
- Creators
- Lorenz Adlung (null) - The Weizmann Institute of Science, Department of ImmunologyEran Elinav (null) - The Weizmann Institute of Science, Department of ImmunologyTim F. Greten (null) - Center for Cancer Research (United States, Bethesda) - CCRFirouzeh Korangy (null) - Center for Cancer Research (United States, Bethesda) - CCR
- Resource Type
- Editorial material
- Publication Details
- Nature Cancer, Vol.1(4), pp.379-381; Apr/2020
- Number of pages
- 3
- Language
- English
- DOI
- https://doi.org/10.1038/s43018-020-0059-x
- Grant note
- L.A. received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska‐Curie Grant Agreement No. 842203. E.E. is the incumbent of the Sir Marc and Lady Tania Feldmann Professorial Chair, a senior fellow at the Canadian Institute of Advanced Research (CIFAR) and an international scholar at the Bill & Melinda Gates Foundation and the Howard Hughes Medical Institute. T.F.G. is supported by the Intramural Research Program of the NIH, NCI (ZIA BC 011344).
- Record Identifier
- 993264430403596
Metrics
14 Record Views